Dbv Technologies S A (DBVT) Return on Equity ROE from the second quarter 2026 to second quarter 2025 and annually, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Dbv Technologies S a   (NASDAQ: DBVT)

Dbv Technologies S A 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Dbv Technologies S A in the second quarter 2026?
Dbv Technologies S A recorded a cumulative net loss of $-176 million during 12 months ending in the second quarter 2026, resulting in a negative return on equity (ROE) of -111.62%.

Within the Biotechnology & Pharmaceuticals industry 82 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 3601, from total ROE ranking in the first quarter 2026 at 4333.

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Equity Change 58.05 % 8157.21 % 516.06 % 2.99 % -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -176 -167 -147 -125 -122
Return On Equity (TTM) -111.62 % -117.16 % -175.35 % -258.26 % -255.01 %
DBVT's Total Ranking # 3601 # 4333 # 3871 # 3928 # 4000
Equity (TTM) in Millions 160 239 169 62 101
Seq. Equity Change -33.02 % 41.86 % 172.15 % -38.88 % 3399.5 %
Seq. Net Income Change - - - - -

Back to DBVT Management Effectiveness >> DBVT's 5 Years Annual ROE >> Compare DBVT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 83
Sector # 571
Overall # 3601

Return On Equity Statistics
High Average Low
-43.27 %
-103.23 %
-259.42 %
(Sep 30 2022)   (Mar 31 2025)





DBVT Annual Return On Equity (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Equity in Millions 169 27 140 194 99
Y / Y Equity Change 516.06 % -80.45 % -27.91 % 95.88 % -51.69 %
Net Income in Millions -147 -114 -73 -96 -98
Y / Y Net Income Change - - - - -
Return On Equity -87.05 % -415.76 % -51.88 % -49.51 % -98.52 %

Back to DBVT Management Effectiveness >> DBVT's 5 Years Annual ROE >> Compare DBVT ROE to its Competitors




More Return On Equity Ratios
Biotechnology & Pharmaceuticals Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
DBVT's' Return on Equity at Yahoo Finance
DBVT's Roe Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for DBVT's Competitors
Subscribers only: Roe for Dbv Technologies S A 's Suppliers
Subscribers only: Return On Equity for DBVT's Customers




Companies with similar Return On Equity at Jun 30 2026, within Healthcare Sector ROE

Date modified: 2026-07-18T04:17:57+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.